Comprehensive bioinformatic analysis reveals sorafenib response-related prognostic signature in hepatocellular carcinoma
Our study established a sorafenib response-related prognostic risk prediction model in HCC based on five signature genes (<i>DNASE1L3</i>, <i>ACSL6</i>, <i>ACAN</i>, <i>BRSK1</i> and <i>CD68</i>), which had high predictive precision on sorafenib response.
Authors
- Guoshan Ding
- Liang Wu (ORCID: https://orcid.org/0000-0002-9269-7372)
- Liang Peng (ORCID: https://orcid.org/0000-0002-9555-6524)
- Junfeng Dong (ORCID: https://orcid.org/0000-0003-2257-5983)
- Wenyuan Guo
- Yuanyu Zhao
- M C Yu
- Han-Xiang Zhong
Institutions
- Shanghai Changzheng Hospital (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jgo-2024-1020
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00